Connect your AI

Boston Scientific BSX Financing Cash Flow

Financing Cash Flow at other companies

AbbottABT

$17.31B+942%

TFX

TeleflexTFX

-$44.99M+24.4%

Johnson & JohnsonJNJ

$530M-94.9%

StrykerSYK

-$1.51B-160%

HaemoneticsHAE

-$101.5M—

CONMEDCNMD

-$22.55M+20.6%

Other financials

Income statement

Revenue$5.2B+11.6%

Gross profit$3.6B+12.6%

Operating income$1.1B+19.5%

Net income$1.3B+99.3%

EPS (diluted)$0.90+100%

Balance sheet

Cash & equivalents$850.0M+146%

Total debt$659.0M-94.1%

Total equity$25.9B+16.4%

Total assets$44.4B+10.5%

Cash flow

Operating cash flow$348.0M-35.7%

CapEx$177.0M-5.3%

Free cash flow$171.0M-51.7%

Valuation

Market cap$65.74B-57.3%

P/E18.5×-43.2×

P/S3.2×-5.1×

Profitability

Gross margin69.2%+0.5pp

Operating margin18.4%+2.2pp

Net margin17.3%+5.7pp

FCF margin16.9%-0.3pp

Returns & leverage

Return on equity14.8%+5.2pp

Debt / equity0×-0.5×

Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Boston Scientific's financing cash flow?: Boston Scientific (BSX) reported financing cash flow of -$260M in Q1 2026.
How has Boston Scientific's financing cash flow changed year-over-year?: Boston Scientific's financing cash flow decreased by 211.6% year-over-year, from $233M to -$260M.
What is the long-term trend for Boston Scientific's financing cash flow?: Over 2 years (2022 to 2025), Boston Scientific's financing cash flow has grown at a -15.2% compound annual growth rate (CAGR), from -$549M to -$395M.
What does financing cash flow mean?: Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.